用TNFRSF11B修改的带介质干细胞作为一种新的骨相关疾病策略,通过抑制骨质细胞活性来抑制骨质细胞活动

Mina Ding1,2, Qian Ding2, Zhijie Liu2

  • 1Shenzhen Key Laboratory of Metabolic Health, Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

概括

瘤坏死因子受体超级家族11B成员 (TNFRSF11B) 在带介质干细胞 (UCMSCs) 中过度表达不会增强骨质生成,但抑制骨质细胞分化,这表明在骨重塑中发挥了作用.